Skip to main content
. 2023 Jan 23;13:1247. doi: 10.1038/s41598-023-28259-y

Figure 2.

Figure 2

Predictive performance of the reduced CR, Organ Dysfunction, and Mortality signatures among patients of the COVID-19 patient cohorts. (a) Accuracy/AUCs across a tenfold repeated cross validation scheme (i.e., total 100 folds) using logistic regression. (b) Kaplan Meier curves of patients with High or Low Mortality signature enrichment in all patients (i.e., early and late sampled patients). Time to mortality was assessed over 30 days, with the baseline time being the day of sampling. Patients were stratified into either High (score ≥ 0; n = 60) or Low (score < 0; n = 64) signature expression based on GSVA enrichment statistics, and this was used as a predictor of 30-day survival.